A Scots dementia expert predicts there will be a cure for Alzheimer’s in 10 years. Professor Craig Ritchie also believes things will move so quickly that advanced cases of dementia in the future ...

World-leading dementia specialist Professor Craig Ritchie, founder and CEO of innovative neuroscience firm Scottish Brain ...

There are numerous causes of memory and thinking difficulties. Many, including Alzheimer's disease, are treatable. Others, such as depression, thyroid problems, severe nutritional deficiency, or ...

Professor Richard Morris, of Edinburgh's department of neuroscience, said past attempts to find a cure for Alzheimer's had been hampered because there was no way of testing short-term memory in ...

Ways to lower your risk of Alzheimer's No single behaviour is guaranteed to prevent dementia - but there's lots of evidence ... may open up new avenues for treatment by either halting the toxic ...

LAFAYETTE, Ind. — Time with a loved one diagnosed with Alzheimer's disease is precious, and a new first-of-its-kind treatment now offered at IU Health Arnett aims to prolong that time.

Alzheimer's disease affects memory, thinking and behaviour, and while age stands as the predominantly known risk factor, your lifestyle choices can also sway the odds. An enlightening article ...

SALT LAKE CITY — After years of stagnation in the search for a cure for Alzheimer's — or at least breakthroughs — 2024 brought several exciting findings and confirmed others regarding the ...

A new surgical treatment for Alzheimer’s disease is showing promise in a clinical trial under way in Chinese hospitals. One doctor taking part in the trial at a hospital in Changsha, Hunan ...

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen's Leqembi received approval in January ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... efficacy or safety. There is no guarantee ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...